PspA Diversity, Serotype Distribution and Antimicrobial Resistance of Invasive Pneumococcal Isolates from Paediatric Patients in Shenzhen, China

References

• Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol. 2008;6(4):288–301. doi:10.1038/nrmicro187118340341
   PubMed Web of Science ®Google Scholar
• Subramanian K, Henriques-Normark B, Normark S. Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: from nasopharyngeal colonizer to intracellular pathogen. Cell Microbiol. 2019;21(11):e13077. doi:10.1111/cmi.1307731251447
   PubMed Web of Science ®Google Scholar
• Engholm DH, Kilian M, Goodsell DS, et al. A visual review of the human pathogen Streptococcus pneumoniae. FEMS Microbiol Rev. 2017;41(6):854–879. doi:10.1093/femsre/fux03729029129
   PubMed Web of Science ®Google Scholar
• Li Q, Li Y, Yi Q, et al. Prognostic roles of time to positivity of blood culture in children with Streptococcus pneumoniae bacteremia. Eur J Clin Microbiol Infect Dis. 2019;38(3):457–465. doi:10.1007/s10096-018-03443-530680552
   PubMed Web of Science ®Google Scholar
• Paton JC, Trappetti C. Streptococcus pneumoniae capsular polysaccharide. Microbiol Spectr. 2019;7(2). doi:10.1128/microbiolspec.GPP3-0019-2018
   Web of Science ®Google Scholar
• Dorosti H, Eslami M, Negahdaripour M, et al. Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine. J Biomol Struct Dyn. 2019;37(13):3524–3535. doi:10.1080/07391102.2018.151946030634893
   PubMed Web of Science ®Google Scholar
• Marra F, Vadlamudi NK. Efficacy and safety of the pneumococcal conjugate-13 valent vaccine in adults. Aging Dis. 2019;10(2):404–418. doi:10.14336/ad.2018.051231011485
   PubMed Web of Science ®Google Scholar
• Balsells E, Guillot L, Nair H, Kyaw MH. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis. PLoS One. 2017;12(5):e0177113. doi:10.1371/journal.pone.017711328486544
   PubMed Web of Science ®Google Scholar
• Hanquet G, Krizova P, Valentiner-Branth P, et al. Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination. Thorax. 2019;74(5):473–482. doi:10.1136/thoraxjnl-2018-21176730355641
   PubMed Web of Science ®Google Scholar
• Savulescu C, Krizova P, Lepoutre A, et al. Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study. Lancet Respir Med. 2017;5(8):648–656. doi:10.1016/S2213-2600(17)30110-828359798
   PubMed Web of Science ®Google Scholar
• Bogaert D, Hermans PW, Adrian PV, et al. Pneumococcal vaccines: an update on current strategies. Vaccine. 2004;22(17–18):2209–2220. doi:10.1016/j.vaccine.2003.11.03815149779
   PubMed Web of Science ®Google Scholar
• McDaniel LS, Sheffield JS, Delucchi P, Briles DE. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect Immun. 1991;59(1):222–228. doi:10.1128/IAI.59.1.222-228.19911987036
   PubMed Web of Science ®Google Scholar
• Nabors GS, Braun PA, Herrmann DJ, et al. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine. 2000;18(17):1743–1754. doi:10.1016/S0264-410X(99)00530-710699322
   PubMed Web of Science ®Google Scholar
• Briles DE, Hollingshead SK, King J, et al. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis. 2000;182(6):1694–1701. doi:10.1086/31760211069242
   PubMed Web of Science ®Google Scholar
• Entwisle C, Hill S, Pang Y, et al. Safety and immunogenicity of a novel multiple antigen pneumococcal vaccine in adults: a Phase 1 randomised clinical trial. Vaccine. 2017;35(51):7181–7186. doi:10.1016/j.vaccine.2017.10.07629132988
   PubMed Web of Science ®Google Scholar
• Hollingshead SK, Becker R, Briles DE. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect Immun. 2000;68(10):5889–5900. doi:10.1128/IAI.68.10.5889-5900.200010992499
   PubMed Web of Science ®Google Scholar
• Mukerji R, Hendrickson C, Genschmer KR, et al. The diversity of the proline-rich domain of pneumococcal surface protein A (PspA): potential relevance to a broad-spectrum vaccine. Vaccine. 2018;36(45):6834–6843. doi:10.1016/j.vaccine.2018.08.04530293761
   PubMed Web of Science ®Google Scholar
• Briles DE, Hollingshead SK, Nabors GS, et al. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine. 2000;19(Suppl 1):S87–95. doi:10.1016/S0264-410X(00)00285-111163470
   PubMed Web of Science ®Google Scholar
• Hollingshead SK, Baril L, Ferro S, et al. Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries. J Med Microbiol. 2006;55(2):215–221. doi:10.1099/jmm.0.46268-016434715
   PubMed Web of Science ®Google Scholar
• Pimenta FC, Ribeiro-Dias F, Brandileone MC, et al. Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil. J Clin Microbiol. 2006;44(8):2838–2843. doi:10.1128/JCM.00156-0616891500
   PubMed Web of Science ®Google Scholar
• Rolo D, Ardanuy C, Fleites A, et al. Diversity of pneumococcal surface protein A (PspA) among prevalent clones in Spain. BMC Microbiol. 2009;9(1):80. doi:10.1186/1471-2180-9-8019419534
   PubMed Web of Science ®Google Scholar
• Hotomi M, Togawa A, Kono M, et al. PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in Japan. PLoS One. 2013;8(3):e58124. doi:10.1371/journal.pone.005812423483982
   PubMed Web of Science ®Google Scholar
• Letunic I, Bork P. 20 years of the SMART protein domain annotation resource. Nucleic Acids Res. 2018;46(D1):D493–D496. doi:10.1093/nar/gkx92229040681
   PubMed Web of Science ®Google Scholar
• Letunic I, Doerks T, Bork P. SMART: recent updates, new developments and status in 2015. Nucleic Acids Res. 2015;43(D1):D257–260. doi:10.1093/nar/gku94925300481
   PubMed Web of Science ®Google Scholar
• Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44(1):124–131. doi:10.1128/JCM.44.1.124-131.200616390959
   PubMed Web of Science ®Google Scholar
• Ronaghi M, Elahi E. Pyrosequencing for microbial typing. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;782(1–2):67–72. doi:10.1016/s1570-0232(02)00693-1
   Web of Science ®Google Scholar
• Echániz-Aviles G, Guerreiro SI, Silva-Costa C, et al. Streptococcus pneumoniae serotype 3 in mexico (1994 to 2017): decrease of the unusual clonal complex 4909 lineage following PCV13 introduction. J Clin Microbiol. 2019;57(1). doi:10.1128/JCM.01354-18
   Web of Science ®Google Scholar
• Mothibeli KM, Du Plessis M, von Gottberg A, et al. An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa. J Clin Microbiol. 2010;48(1):184–191. doi:10.1128/JCM.01011-0919889905
   PubMed Web of Science ®Google Scholar
• Martens P, Worm SW, Lundgren B, et al. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis. 2004;4(1):21. doi:10.1186/1471-2334-4-2115228629
   PubMed Web of Science ®Google Scholar
• Andrews NJ, Waight PA, Burbidge P, et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis. 2014;14(9):839–846. doi:10.1016/S1473-3099(14)70822-925042756
   PubMed Web of Science ®Google Scholar
• Choi EH, Zhang F, Lu YJ, Malley R. Capsular polysaccharide (CPS) release by serotype 3 pneumococcal strains reduces the protective effect of anti-type 3 CPS antibodies. Clin Vaccine Immunol. 2016;23(2):162–167. doi:10.1128/CVI.00591-1526677201
   PubMed Web of Science ®Google Scholar
• Azarian T, Mitchell PK, Georgieva M, et al. Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci. PLoS Pathog. 2018;14(11):e1007438. doi:10.1371/journal.ppat.100743830475919
   PubMed Web of Science ®Google Scholar
• Chen K, Zhang X, Shan W, et al. Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: a systematic review and meta-analysis. Hum Vaccin Immunother. 2018;14(6):1453–1463. doi:10.1080/21645515.2018.143522429451838
   PubMed Web of Science ®Google Scholar
• Li -X-X, Xiao S-Z, Gu -F-F, et al. Serotype distribution, antimicrobial susceptibility, and Multilocus Sequencing Type (MLST) of from adults of three hospitals in Shanghai, China. Front Cell Infect Microbiol. 2019;9:407. doi:10.3389/fcimb.2019.0040731828048
   PubMed Web of Science ®Google Scholar
• Kawaguchiya M, Urushibara N, Aung MS, et al. Association between pneumococcal surface protein a family and genetic/antimicrobial resistance traits of non-invasive pneumococcal isolates from adults in Northern Japan. Microb Drug Resist. 2019;25(5):744–751. doi:10.1089/mdr.2018.026730676875
   PubMed Web of Science ®Google Scholar
• Wang CY, Chen YH, Fang C, et al. Antibiotic resistance profiles and multidrug resistance patterns of Streptococcus pneumoniae in pediatrics: a multicenter retrospective study in mainland China. Medicine. 2019;98(24):e15942. doi:10.1097/md.000000000001594231192930
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen M, Yu Y, et al. Antimicrobial susceptibility among and collected globally between 2015 and 2017 as part of the Tigecycline Evaluation and Surveillance Trial (TEST). Infect Drug Resist. 2019;12:1209–1220. doi:10.2147/idr.s20312131190909
   PubMed Web of Science ®Google Scholar
• Chiba N, Murayama SY, Morozumi M, et al. Genome evolution to penicillin resistance in serotype 3 streptococcus pneumoniae by capsular switching. Antimicrob Agents Chemother. 2017;61(9). doi:10.1128/AAC.00478-17
   Web of Science ®Google Scholar